Overcoming T-cell-mediated immunopathology to achieve safe respiratory syncytial virus vaccination

@RolandBakerIII @Hospgone The plan seems to be to wait for things to go horribly wrong first and then do the research that might have prevented it. Lots of very interesting work went into understanding RSV vaccine enhancement which we could try to repli…

@BallouxFrancois ... It may have been a similar problem with RSV. The newer vaccines (mRNA and vector) tend to give a better T-cell response. The phenomenon should be viewed as vaccine induced enhancement not necessarily ADE. https://t.co/uegxJghQTy